Physician profile
Casey Mcgrath
NPI 1821632324
$9,018.40
in general payments reported to CMS, 2019-2025
37 companies · $2,125 in 2025
The $2,125 reported for 2025 was more than what 92% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,694 · 2022: $1,444 · 2023: $1,836 · 2024: $1,920 · 2025: $2,125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,880.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,022.29 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $1,299.46 | 2021-2025 | |
| Lilly USA, LLC | $863.56 | 2021-2025 | Mounjaro |
| Novo Nordisk INC | $858.67 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $759.62 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Pfizer INC. | $470.81 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $300.47 | 2021-2025 | Relistor, Xifaxan, Trulance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $289.83 | 2021-2025 | Caplyta |
| Exact Sciences Corporation | $249.43 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $228.36 | 2021-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $196.00 | 2021-2023 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $133.31 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $121.97 | 2023-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $108.96 | 2021-2022 | |
| Corcept Therapeutics | $105.91 | 2024 | Korlym |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Mcgrath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.